secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001193125-24-215180
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Verrica confirms separation agreements with former CCO Joe Bonaccorso
---------------------------------------------------------------------

- On August 30, 2024, Verrica entered into Release and Consulting Agreements with former CCO Joe Bonaccorso.
- Terms of the agreements were disclosed on August 27, 2024 and remain unchanged.
- The agreements formalize Bonaccorso's departure as Chief Commercial Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524215180/0001193125-24-215180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524215180/d894672d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-215180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer